Valuation: Bure Equity AB

Market Cap 22.86B 2.33B 2.08B 1.92B 1.74B 3.25B 221B 3.31B 9.18B 116B 8.73B 8.55B 366B P/E 2024
4.94x
P/E 2025 -3.91x
Enterprise Value 22.52B 2.29B 2.05B 1.89B 1.71B 3.2B 218B 3.26B 9.04B 114B 8.6B 8.42B 361B EV / Sales 2024
4.74x
EV / Sales 2025 -3.91x
Free-Float
70.39%
Yield 2024
0.72%
Yield 2025 1.11%
1 day-1.16%
1 week+4.72%
Current month-3.04%
1 month-3.04%
3 months+17.14%
6 months+14.68%
Current year+24.07%
1 week 292.4
Extreme 292.4
310.8
1 month 286.4
Extreme 286.4
319
Current year 190.2
Extreme 190.2
330.6
1 year 190.2
Extreme 190.2
330.6
3 years 190.2
Extreme 190.2
421.2
5 years 171.3
Extreme 171.3
474.6
10 years 86.8
Extreme 86.8
489.2
Manager TitleAgeSince
Chief Executive Officer 55 22/04/2013
Director of Finance/CFO 58 01/10/2013
Chief Investment Officer 46 01/01/2019
Director TitleAgeSince
Director/Board Member 56 30/04/2010
Chairman 62 22/04/2013
Director/Board Member 60 04/05/2015
Date Insider Type Main position Quantity % Market Cap. Importance
21/8/26 Buy

Director

1,100 0.0015%
1/6/26 Buy

Chief Financial Officer

1,069 0.0014%
26/5/26 Buy 67,000 0.0904%
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%+4.72%+7.82%+42.42% 2.33B
-0.14%+3.15%+32.63%+109.55% 132B
-0.57%+3.26%+30.63%+84.98% 22.89B
+0.12%+1.80%+24.82%+61.29% 17.14B
+1.37%+4.23%+20.43%+164.81% 16.07B
-0.51%+3.19%+13.45%+29.77% 14.69B
+0.05%+4.09%-11.57%+14.26% 14.08B
+0.39%-0.93%+21.31%+35.90% 12.22B
+0.69%-8.54%-17.89%+50.24% 11.98B
-1.08%-1.81%+53.94%+66.39% 11.78B
Average -0.08%+1.82%+17.56%+65.96% 25.54B
Weighted average by Cap. -0.07%+2.91%+25.46%+88.83%

Financials

2024 2025
Net sales 5.81B 591M 529M 487M 441M 825M 56.13B 840M 2.33B 29.52B 2.22B 2.17B 93.11B -4.6B -468M -419M -386M -350M -653M -44.47B -666M -1.85B -23.39B -1.76B -1.72B -73.77B
Net income 5.74B 584M 523M 482M 436M 816M 55.5B 831M 2.31B 29.19B 2.19B 2.15B 92.06B -4.68B -476M -426M -392M -355M -664M -45.21B -677M -1.88B -23.78B -1.79B -1.75B -75B
Net Debt -779M -79.3M -71.02M -65.32M -59.19M -111M -7.53B -113M -313M -3.96B -298M -291M -12.49B -339M -34.51M -30.9M -28.43M -25.76M -48.15M -3.28B -49.05M -136M -1.72B -130M -127M -5.44B
Projected Income Statement - Annual - Bure Equity AB
Logo Bure Equity AB
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Employees
12
Date Price Change Volume
30/10/26 SEK 306.20 -1.16% 46,275
29/10/26 SEK 309.80 +0.19% 141,337
28/10/26 SEK 309.20 +1.24% 69,962
27/10/26 SEK 305.40 +1.53% 67,268
26/10/26 SEK 300.80 +2.87% 78,683
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. BURE Stock